Leading Swiss manufacturer of Class IIb & III Medical Devices for autologous blood cell preparations, RegenLab will exhibit at CCR later this month.

Founded over twenty years ago, RegenLab SA has established itself as the global authority on PRP, with CE certifications and registration with regulatory bodies around the world. Products have been tried, tested, and patented, with over 200 publications, many clinical studies, and over two million treatments performed. 

Hosted at the Excel exhibition center, CCR brings surgical and non-surgical specialties together to discover innovations, learn best practices from world-leading practitioners, and find the latest clinical advancements in the industry.

With education at its core, CCR brings together over 180 exhibitors; In this two-day event, CCR brings together over 3,000 industry professionals to learn, network, and demonstrate the latest advancements with clinical workshops and education sessions led by some of the biggest names in the industry. 

Mark Johnson, UK Director at RegenLab, says: “We look forward to attending and exhibiting at CCR to see the whole industry come together again for this fantastic two-day event. We will display all our latest innovations for Clinicians to see and learn more about how they can advance their clinical treatments.”

At CCR, RegenLab hopes to educate and inform clinics and practitioners on the following innovations: 

Cellular Matrix – a unique & ground-breaking therapy that combines Hyaluronic acid and PRP, in one medical device (Class iii) to enhance the activity of numerous molecules in platelet-rich plasma. This helps patients achieve more significant, natural anti-aging results such as improved skin tone, laxity, contouring, and rejuvenation.

RegenKIT DERMAL – a product that can treat the signs of anti-aging, acne scarring, and keloid scarring. PRP demonstrates the production of new collagen in the case of skin rejuvenation.

RegenKIT HAIR – helps repair hair loss and boost hair density in patients with androgenetic alopecia. Firmer, denser, and richer hair stimulates hair bulb regeneration by increasing blood flow and enhancing follicular cell proliferation.

RegenKIT INTIMACY – PRP can be used to treat lichen sclerosis and female sexual dysfunction: RegenPRP injection greatly enhances individual measurements of desire, arousal, lubrication, and orgasm.

Mark adds: “CCR is always a fantastic event for RegenLab. It provides us with the opportunity to reconnect with experts in the industry from around the world, giving us a chance to introduce clinics to our products and connect with potential new customers, alongside catching up with our loyal customers.”

All visitors to the RegenLab stand will automatically be entered into an exclusive prize draw to win a copy of the in-depth educational resource book, Aesthetics Medicine Clinical summary of RegenLab results.

RegenLab remains committed to providing products of the highest quality and safety. In the last five years, they have treated more than two million patients. 
RegenLab’s Platelet-rich plasma (PRP) is proven to deliver regenerative effects and harness the body’s abilities, due to the high-yielding plasma harvested from the patient’s blood. 

Since its inception 20 years ago, RegenLab has enjoyed a great deal of global success in device sales due research-driven development, Quality Swiss manufacturing & the acceptance of the treatments’ holistic and restorative nature.

RegenLab will be on stand B32. The CCR exhibition takes place at the London Excel 13-14th October 2022.